These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 38545106)

  • 1. Recent advances in different interactions between toll-like receptors and hepatitis B infection: a review.
    Soleiman-Meigooni S; Yarahmadi A; Kheirkhah AH; Afkhami H
    Front Immunol; 2024; 15():1363996. PubMed ID: 38545106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-like receptor (TLR)-mediated innate immune responses in the control of hepatitis B virus (HBV) infection.
    Zhang E; Lu M
    Med Microbiol Immunol; 2015 Feb; 204(1):11-20. PubMed ID: 25550115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of microRNA by hepatitis B virus infection and their possible association with control of innate immunity.
    Jiang X; Kanda T; Wu S; Nakamura M; Miyamura T; Nakamoto S; Banerjee A; Yokosuka O
    World J Gastroenterol; 2014 Jun; 20(23):7197-206. PubMed ID: 24966589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of Toll-like receptors to the control of hepatitis B virus infection by initiating antiviral innate responses and promoting specific adaptive immune responses.
    Ma Z; Zhang E; Yang D; Lu M
    Cell Mol Immunol; 2015 May; 12(3):273-82. PubMed ID: 25418467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptor-mediated innate immunity orchestrates adaptive immune responses in HBV infection.
    Du Y; Wu J; Liu J; Zheng X; Yang D; Lu M
    Front Immunol; 2022; 13():965018. PubMed ID: 35967443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-Like Receptor Response to Hepatitis B Virus Infection and Potential of TLR Agonists as Immunomodulators for Treating Chronic Hepatitis B: An Overview.
    Kayesh MEH; Kohara M; Tsukiyama-Kohara K
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice.
    Wu J; Lu M; Meng Z; Trippler M; Broering R; Szczeponek A; Krux F; Dittmer U; Roggendorf M; Gerken G; Schlaak JF
    Hepatology; 2007 Dec; 46(6):1769-78. PubMed ID: 17929296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms of toll-like receptors and their pathways in viral hepatitis.
    Sawhney R; Visvanathan K
    Antivir Ther; 2011; 16(4):443-58. PubMed ID: 21685532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells.
    Wu J; Meng Z; Jiang M; Pei R; Trippler M; Broering R; Bucchi A; Sowa JP; Dittmer U; Yang D; Roggendorf M; Gerken G; Lu M; Schlaak JF
    Hepatology; 2009 Apr; 49(4):1132-40. PubMed ID: 19140219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hippo Pathway Counter-Regulates Innate Immunity in Hepatitis B Virus Infection.
    Luo X; Zhang R; Lu M; Liu S; Baba HA; Gerken G; Wedemeyer H; Broering R
    Front Immunol; 2021; 12():684424. PubMed ID: 34113355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptor signaling inhibits hepatitis B virus replication in vivo.
    Isogawa M; Robek MD; Furuichi Y; Chisari FV
    J Virol; 2005 Jun; 79(11):7269-72. PubMed ID: 15890966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in Targeting the Innate and Adaptive Immune Systems to Cure Chronic Hepatitis B Virus Infection.
    Meng Z; Chen Y; Lu M
    Front Immunol; 2019; 10():3127. PubMed ID: 32117201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of toll-like receptors single nucleotide polymorphisms with HBV and HCV infection: research status.
    Xu Y; Xue W; Gao H; Cui J; Zhao L; You C
    PeerJ; 2022; 10():e13335. PubMed ID: 35462764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of hepatitis B virus replication by interferons and Toll-like receptor signaling pathways.
    Pei RJ; Chen XW; Lu MJ
    World J Gastroenterol; 2014 Sep; 20(33):11618-29. PubMed ID: 25206268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between polymorphisms in toll-like receptor genes and the activity of hepatitis B virus among treatment-naïve patients: a case-control study in a Han Chinese population.
    Lin Y; Gao ZX; Shen X; Chen MJ; Li YT; Li SL; Lin HL; Zhao QF; Liu F; Niu JJ
    BMC Infect Dis; 2018 Jan; 18(1):28. PubMed ID: 29320990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll Like Receptor 3 Polymorphisms in Hepatitis B Virus Infection.
    EzzEl-Din AM; Galal SH; Ahmed AO; Kamel SI; Kamal DT
    Egypt J Immunol; 2017 Jun; 24(2):173-185. PubMed ID: 29528590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential Effects of Toll-Like Receptor Signaling on the Activation of Immune Responses in the Upper Respiratory Tract.
    Xu M; Li N; Fan X; Zhou Y; Bi S; Shen A; Wang B
    Microbiol Spectr; 2022 Feb; 10(1):e0114421. PubMed ID: 35196817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between Hepatitis B Virus and Toll-Like Receptors: Current Status and Potential Therapeutic Use for Chronic Hepatitis B.
    Ma Z; Cao Q; Xiong Y; Zhang E; Lu M
    Vaccines (Basel); 2018 Jan; 6(1):. PubMed ID: 29337856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like Receptor Response to Human Immunodeficiency Virus Type 1 or Co-Infection with Hepatitis B or C Virus: An Overview.
    Kayesh MEH; Kohara M; Tsukiyama-Kohara K
    Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.